A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer

This prospective trial demonstrated that SLN biopsy plus side-specific LAD, when SLN is not detected, is a reasonable alternative to a complete LAD in high-risk endometrial cancer.